J Le Houezec

Summary

Affiliation: Pharmacia Corporation
Country: USA

Publications

  1. ncbi request reprint Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review
    J Le Houezec
    Pharmacia R and D Consumer HealthCare, Rennes, France
    Int J Tuberc Lung Dis 7:811-9. 2003
  2. ncbi request reprint [Smoking reduction and temporary abstinence: new approaches for smoking cessation]
    J Le Houezec
    Pharmacia, R and D Consumer Healthcare, Helsingborg, Suède
    J Mal Vasc 28:293-300. 2003
  3. ncbi request reprint [What smoking cessation interventions are effective in pregnant women?]
    J Le Houezec
    Amzer Glas, 176, rue de Brest, 35000 Rennes
    J Gynecol Obstet Biol Reprod (Paris) 34:3S182-93. 2005
  4. pmc WHO Europe evidence based recommendations on the treatment of tobacco dependence
    M Raw
    Guy s King s and St Thomas School of Medicine, University of London, London, UK
    Tob Control 11:44-6. 2002
  5. ncbi request reprint Early emotional disturbances during nicotine patch therapy in subjects with and without a history of depression
    S Carton
    université Paris V René Descartes, Institut de Psychologie, Laboratoire de Psychologie Clinique et de Psychopathologie, 71, av Edouard Vaillant, 92774 Cedex, Boulogne Billancourt, France
    J Affect Disord 72:195-9. 2002
  6. ncbi request reprint Chronic high dose transdermal nicotine in Parkinson's disease: an open trial
    G Villafane
    Service de Neurologie, Hopital Henri Mondor, and unité INSERM U841 NPI, Creteil, France
    Eur J Neurol 14:1313-6. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review
    J Le Houezec
    Pharmacia R and D Consumer HealthCare, Rennes, France
    Int J Tuberc Lung Dis 7:811-9. 2003
    ..Combination therapy (e.g., patch+gum, patch+inhaler), higher dosage, temporary abstinence or smoking reduction (using NRT to reduce smoke intake) may be needed to help more smokers to quit...
  2. ncbi request reprint [Smoking reduction and temporary abstinence: new approaches for smoking cessation]
    J Le Houezec
    Pharmacia, R and D Consumer Healthcare, Helsingborg, Suède
    J Mal Vasc 28:293-300. 2003
    ..Smoking reduction also promotes abstinence in smokers who are unable or unwilling to quit smoking abruptly. NRT is well tolerated for smoking reduction, and nicotine intake does not increase during concomitant use of NRT and smoking...
  3. ncbi request reprint [What smoking cessation interventions are effective in pregnant women?]
    J Le Houezec
    Amzer Glas, 176, rue de Brest, 35000 Rennes
    J Gynecol Obstet Biol Reprod (Paris) 34:3S182-93. 2005
    ..This registry would allow health professionals to share their experience and should encourage them to use pharmacotherapy more frequently and lift psychological barriers concerning its use in pregnant women...
  4. pmc WHO Europe evidence based recommendations on the treatment of tobacco dependence
    M Raw
    Guy s King s and St Thomas School of Medicine, University of London, London, UK
    Tob Control 11:44-6. 2002
  5. ncbi request reprint Early emotional disturbances during nicotine patch therapy in subjects with and without a history of depression
    S Carton
    université Paris V René Descartes, Institut de Psychologie, Laboratoire de Psychologie Clinique et de Psychopathologie, 71, av Edouard Vaillant, 92774 Cedex, Boulogne Billancourt, France
    J Affect Disord 72:195-9. 2002
    ..The goal of this study was to compare development of emotional symptomatology during smoking cessation with transdermal nicotine patches in subjects with and without a history of depression...
  6. ncbi request reprint Chronic high dose transdermal nicotine in Parkinson's disease: an open trial
    G Villafane
    Service de Neurologie, Hopital Henri Mondor, and unité INSERM U841 NPI, Creteil, France
    Eur J Neurol 14:1313-6. 2007
    ..These results confirm the feasibility of chronic high dose nicotinic treatment in PD but warrant validation of the beneficial effects by a randomized controlled trial...